Psychosocial Factors and Recovery After Acute Myocardial Infarction in Younger Women.


Journal

Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969

Informations de publication

Date de publication:
24 04 2019
Historique:
entrez: 26 4 2019
pubmed: 26 4 2019
medline: 20 2 2020
Statut: epublish

Résumé

To explain sex and gender approaches to studying acute myocardial infarction (AMI) risk and outcomes in younger women (18-55 years). More specifically, by looking at the AMI care pathway-from AMI risk to receiving acute and follow-up outpatient care to longer term AMI outcomes-we will examine where potential psychosocial factors may be associated with inequalities in AMI care and outcomes in younger women. Despite recent declines in AMI incidence, morbidity, and mortality rates, younger women stand out as a group whose incidence has risen and who face worse outcomes following AMI, as compared with other groups. A focus on gender, rather than the binary, biological sex construct, allowed researchers to better understand potential pathways as to why younger women are facing this risk. Feminine traits and disproportionate exposures to psychosocial stressors in society at large may be correlated with inequalities in AMI care and further AMI outcomes in younger women. Psychosocial interventions in women with AMI that have proven to be successful have embraced this wider gender concept. Adopting a wider gender-concept to understand roles and demands that are placed on individuals that make them more at risk to experience psychosocial stressors and make it more challenging to organize self-care, get access to care, and equitable care may be needed.

Identifiants

pubmed: 31020453
doi: 10.1007/s11886-019-1140-x
pii: 10.1007/s11886-019-1140-x
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

50

Références

Circ Cardiovasc Qual Outcomes. 2009 Jan;2(1):25-32
pubmed: 20031809
Dialogues Clin Neurosci. 2007;9(1):71-83
pubmed: 17506227
CMAJ. 2014 Apr 15;186(7):497-504
pubmed: 24638026
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
J Health Soc Behav. 1995 Mar;36(1):1-10
pubmed: 7738325
Arch Intern Med. 2006 Apr 24;166(8):876-83
pubmed: 16636213
Psychosom Med. 2010 Nov;72(9):842-54
pubmed: 20841557
J Am Heart Assoc. 2016 Oct 14;5(10):
pubmed: 27742618
Can J Cardiol. 2016 Dec;32(12):1447-1453
pubmed: 27683172
Nat Rev Cardiol. 2012 Apr 03;9(6):360-70
pubmed: 22473079
Circ Cardiovasc Qual Outcomes. 2010 Nov;3(6):684-93
pubmed: 21081748
Can J Cardiol. 2014 Jan;30(1):109-17
pubmed: 24238757
Int J Equity Health. 2005 Jul 13;4:11
pubmed: 16014164
J Am Coll Cardiol. 2016 Jan 19;67(2):127-135
pubmed: 26791057
Am Heart J. 2006 Jan;151(1):206-12
pubmed: 16368320
J Am Heart Assoc. 2015 Apr 02;4(4):
pubmed: 25836055
J Occup Environ Med. 2011 Jan;53(1):2-7
pubmed: 21187788
JAMA Psychiatry. 2014 Jan;71(1):13-4
pubmed: 24227264
Curr Med Res Opin. 2008 Feb;24(2):461-8
pubmed: 18194592
Circulation. 2017 May 2;135(18):1762-1764
pubmed: 28461419
Circulation. 2015 Jun 2;131(22):1971-80
pubmed: 25862743
J Am Coll Cardiol. 2008 Apr 1;51(13):1237-46
pubmed: 18371552
Psychosom Med. 2015 Jun;77(5):517-26
pubmed: 25984818
Psychosom Med. 2007 Jul-Aug;69(6):491-2
pubmed: 17641143
Eur Heart J Acute Cardiovasc Care. 2017 Oct;6(7):610-622
pubmed: 27485141
Am Heart J. 2012 May;163(5):741-746.e2
pubmed: 22607849
Psychosom Med. 2001 Mar-Apr;63(2):257-66
pubmed: 11292273
Circulation. 2015 Sep 15;132(11):997-1002
pubmed: 26302759
J Am Coll Cardiol. 2014 Jul 29;64(4):337-45
pubmed: 25060366
Circulation. 2015 Apr 14;131(15):1324-32
pubmed: 25792558
Circ Cardiovasc Qual Outcomes. 2011 Nov 1;4(6):626-33
pubmed: 22010201
Circulation. 2017 Feb 7;135(6):521-531
pubmed: 28153989
J Cardiopulm Rehabil Prev. 2015 Mar-Apr;35(2):103-13
pubmed: 25412222
Circulation. 2011 Feb 1;123(4):e18-e209
pubmed: 21160056
Circulation. 2017 May 2;135(18):1681-1689
pubmed: 28209727
Lancet. 2004 Sep 11-17;364(9438):937-52
pubmed: 15364185
Scand J Work Environ Health. 2006 Dec;32(6):431-42
pubmed: 17173200
Int J Equity Health. 2009 May 06;8:14
pubmed: 19419579
J Am Coll Cardiol. 2012 Oct 30;60(18):1756-63
pubmed: 23040574

Auteurs

Kim G Smolderen (KG)

Saint Luke's Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO, 64111, USA. smolderenk@umkc.edu.
UMKC School of Medicine - Biomedical & Health Informatics, Kansas City, MO, 64108, USA. smolderenk@umkc.edu.

Anna Brush (A)

University of Virginia, Charlottesville, VA, USA.

Rachel P Dreyer (RP)

Center for Outcomes Research and Evaluation (CORE), New Haven, CT, USA.
Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH